Page 726 - Cardiac Nursing

qxd
qxd
7
04.
5-7
5-7
04.
7
/1/
09
09
p65
Ap
/1/
p65
e
702
702
e
a
g
g
Ap
AM
49
49
AM
a
P
P
0-c
0-c
28_
9:
28_
L L LWB
LWBK340-c28_p655-704.qxd 7/1/09 9:9:49 AM Page 702 Aptara a a
LWB
K34
K34
tar
tar
702 PA R T I V / Pathophysiology and Management Disease
would minimize complication from multiple leads and could po- 19. Sheldon, R. S., & Hersi, A. (2007). Evolving indications for pacing: Hy-
tentially increase the number of patients receiving ICDs, as it pertrophic cardiomyopathy, sleep apnea, long QT syndromes, and neu-
would be a less invasive option. ICDs are not just for cardiac ar- rally mediated syncope syndromes. In K. A. Ellenbogen, G. N. Kay, C.-P.
Lau, et al. (Eds.), Clinical cardiac pacing, defibrillation, and resynchroniza-
rest survivors. They are also placed as the first-line defense in pre- tion therapy (3rd ed., pp. 473–498). Philadelphia: Saunders Elsevier.
vention of sudden cardiac arrest from cardiac causes. For all eligi- 20. Shanker, A., & Saksena, S. (2001). Cardiac pacemakers. In P. J. Podrid
ble patients to receive an ICD, the benefits of the device need to & P. R. Kowey (Eds.), Cardiac arrhythmia: Mechanisms, diagnosis, and
be understood, and disparities need to be eliminated. Health care management (2nd ed., pp. 323–356). Philadelphia: Lippincott Williams
& Wilkins.
providers must become comfortable with the ICD and its capa- 21. Reade, M. C. (2007). Temporary epicardial pacing after cardiac surgery:
bilities and limitations. Part 1: General considerations in the management of epicardial pacing.
Anaesthesia, 62, 264–271.
22. Bernstein, A. D., Daubert, J.-C., Fletcher, R. D., et al. (2002). The re-
REFERENCES vised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and
multisite pacing. Pacing and Clinical Electrophysiology, 25, 260–264.
1. Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., et al. (2008). 23. Barold, S. S., Stroobandt, R. X., & Sinnaeve, A. F. (2004). Cardiac pace-
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac makers step by step. Malden, MA: Blackwell Futura.
rhythm abnormalities. A report of the American College of Cardiol- 24. Kenny, T. (2005). The nuts and bolts of cardiac pacing. Malden, MA:
ogy/American Heart Association Task Force on Practice Guidelines Blackwell Futura.
(Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline 25. Pinski, S. L. (2007). Electromagnetic interference and implantable de-
Update for Implantation of Cardiac Pacemakers and Antiarrhythmia De- vices. In K. A. Ellenbogen, G. N. Kay, C.-P. Lau, et al. (Eds.), Clinical
7
7
vices). Circulation, 117, e350–e3408. cardiac pacing, defibrillation, and resynchronization therapy (3rd ed.,
2. Vijayaraman, P., & Ellenbogen, K. A. (2008). Bradyarrhythmias and pp. 1149–1176). Philadelphia: Saunders Elsevier.
pacemakers. In V. Fuster, R. Walsh, R. O’Rourke et al. (Eds.), Hurst’s the 26. Wang, P. J., Chen, H., Okamura, H., et al. (2007). Timing cycles of im-
heart (8th ed.). New York: McGraw-Hill. plantable devices. In K. A. Ellenbogen, G. N. Kay, C.-P. Lau et al. (Eds.),
3. Hayes, D. L., & Zipes, D. P. (2008). Cardiac pacemakers and car- Clinical cardiac pacing, defibrillation, and resynchronization therapy (3rd
dioverter-defibrillators. In P. Libby, R. O. Bonow, D. L. Mann, et al. ed., pp. 969–1004). Philadelphia: Saunders Elsevier.
(Eds.), Braunwald’s heart disease: A textbook of cardiovascular medicine 27. Love, C. J. (2007). Pacemaker troubleshooting and follow-up. In K. A.
(8th ed., pp. 831–846). Philadelphia: Saunders Elsevier. Ellenbogen, G. Kay, C.-P. Lau, et al. (Eds.), Clinical cardiac pacing, de-
4. Trohman, R. G., Kim, M. H., & Pinski, S. L. (2004). Cardiac pacing: fibrillation, and resynchronization therapy (3rd ed., pp. 1005–1062).
The state of the art. The Lancet, 364, 1701–1719. Philadelphia: Saunders Elsevier.
4
4
5. Prinzen, F., Spinelli, J. C., & Auricchio, A. (2007). Basic physiology 28. Tse, H.-F., & Lau, C.-P. (2007). Sensors for implantable devices: Ideal char-
and hemodynamics of cardiac pacing. In K. A. Ellenbogen, N. G. Kay, acteristics, sensor combinations, and automaticity. In K. A. Ellenbogen, G. N.
C.-P. Lau, et al. (Eds.), Clinical cardiac pacing, defibrillation, and re- Kay, C.-P. Lau, et al. (Eds.), Clinical cardiac pacing, defibrillation, and resyn-
synchronization therapy (3rd ed., pp. 291–335). Philadelphia: Saunders chronization therapy (3rd ed., pp. 201–233). Philadelphia: Saunders Elsevier.
Elsevier. 29. Hasan, A., & Abraham, W. T. (2007). Cardiac resynchronization treat-
6. Abraham, W. T., Fisher, W. G., Smith, A. L., et al., for the Miracle In- ment of heart failure. Annual Review of Medicine 58, 63–74.
vestigatons. (2002). Cardiac resynchronization in chronic heart failure. 30. Flachskampf, F. A., & Voigt, J.-U. (2006). Echocardiographic methods to
6
6
New England Journal of Medicine, 346(24), 1845–1853. select candidates for cardiac resynchronisation therapy. Heart, 92, 424–429.
7. Cazeau, S., Leclercq, C., Lavergne, T., et al. (2001). Effects of multisite 31. Sogaard, P., Egeblad, H., Pedersen, A. K., et al. (2002). Sequential ver-
biventricular pacing in patients with heart failure and intraventricular sus simultaneous biventricular resynchronization for severe heart fail-
6
conduction delay. New England Journal of Medicine, 344(12), 873–880. ure: Evaluation by tissue Doppler imaging. Circulation, 106,
6
8. Saxon, L. A., De Marco, T., & Ellenbogen, K. A. (2007). Clinical trials 2078–2084.
of cardiac resynchronization therapy: Pacemakers and defibrillators. In K. 32. van Gelder, B. M., Bracke, F. A., Lakerveld, L. J. M., et al. (2004). Effect of
A. Ellenbogen, N. G. Kay, C.-P. Lau et al. (Eds.), Clinical cardiac pacing, optimizing the V-V interval on left ventricular contractility in cardiac resyn-
defibrillation, and resynchronization therapy (pp. 385–406). Philadelphia: chronization therapy. American Journal of Cardiology, 93(12), 1500–1503.
Saunders Elsevier. 33. Young, J., Abraham, W. T., Smith, A. L., et al. (2003). Combined cardiac
9. Albouaini, K., Rao, M., Alahmar, A., et al. (2008). Cardiac resynchroni- resynchronization and implantable cardioversion defibrillation in ad-
sation therapy: Evidence based benefits and patient selection. European vanced chronic heart failure: The MIRACLE ICD Trial. JAMA, 289(20),
Journal of Internal Medicine, 19, 165–172. 2685–2694.
10. Goldenberg, I., & Moss, A. J. (2008). Implantable device therapy. 34. Bristow, M., Saxon, L. A., Boehmer, J., et al., for the comparison of med-
Progress in Cardiovascular Diseases, 50(6), 449–474. ical therapy. (2004). Cardiac-resynchronization therapy with or without
11. Saxon, L. A., Kumar, U. N., & De Marco, T. (2008). Cardiac resynchro- an implantable defibrillator in advanced chronic heart failure. New England
nization therapy (biventricular pacing) in heart failure. Retrieved August Journal of Medicine, 350(21), 2140–2150.
12, 2008, from www.uptodateonline.com. 35. Cleland, J. G., Daubert, J.-C., Erdmann, E., et al. (2005). Cardiac Re-
12. Cheng, J., & Arnsdorf, M. F. (2006). The role of pacemakers in the pre- synchronization in Heart Failure (CARE-HF) Study Investigators: The
vention of atrial fibrillation. UpToDate. Retrieved August 15, 2008, from effect of cardiac resynchronization on morbidity and mortality in heart
www.uptodateonline.com. failure. New England Journal of Medicine, 352, 1539–1549.
13. Efremidis, M., Papps, L., Sideris, A., et al. (2008). Management of atrial 36. Linde, C., Leclercq, C., Rex, S., et al. (2002). Long-term benefits of
fibrillation in patients with heart failure. Journal of Cardiac Failure, 14(3), biventricular pacing in congestive heart failure: Results from the MUlti-
232–237. site STimulation in Cardiomyopathy (MUSTIC) study. Journal of the
14. Kalahasty, G., & Ellenbogen, K. A. (2008). The role of pacemakers in the American College of Cardiology, 40(1), 111–118.
management of patients with atrial fibrillation. Medical Clinics of North 37. Barold, S. S., Herweg, B., & Giudici, M. (2005). Electrocardiographic
America, 92, 161–178. follow-up of biventricular pacemakers. Annals of Noninvasive Electrocar-
15. Koebe, J., & Kirchof, P. (2008). Novel non-pharmacological approaches diology, 10(2), 231–255.
for antiarrhythmic therapy of atrial fibrillation. Europace, 10, 433–437. 38. Sweeney, M. O., Hellkamp, A., Ellenbogen, K. A., et al. (2003). Adverse
16. Inoue, N., Ishikawa, T., Sumita, S., et al. (2006). Suppression of atrial effect of ventricular pacing on heart failure and atrial fibrillation among
fibrillation by atrial pacing. Circulation, 70, 1398–1401. patients with normal baseline QRS duration in a clinical trial of pace-
7
17. Bacik, B. M., Muller, D., & Corbisiero, R. (2006). Adaptive bi-atrial maker therapy for sinus node dysfunction. Circulation, 107, 2932–2937.
7
pacing improves the maintenance of sinus rhythm. Pacing and Clinical 39. Sweeney, M. O., & Hellkamp, A. S. (2006). Heart failure during cardiac
Electrophysiology, 30, 492–497. pacing. Circulation, 113, 2082–2088.
18. Sulke, N., Silverbauer, J., Boodhoo, L., et al. (2007). The use of atrial 40. Wilkoff, B., Cook, J., Epstein, A., et al. (2002). Dual-chamber pacing or
overdrive and ventricular rate stabilization pacing algorithms for the pre- ventricular backup pacing in patients with an implantable defibrillator:
vention and treatment of paroxysmal atrial fibrillation: The Pacemaker The Dual chamber and VVI Implantable Defibrillator (DAVID) Trial.
Atrial Fibrillation Suppression (PAFS) Study. Europace, 9, 790–797. JAMA, 288(24), 3115–3123.